Search results for "Reactive"

showing 10 items of 1469 documents

Role of biomarkers in the management of antibiotic therapy : an expert panel review : I - currently available biomarkers for clinical use in acute in…

2013

Abstract In the context of worldwide increasing antimicrobial resistance, good antimicrobial prescribing in more needed than ever; unfortunately, information available to clinicians often are insufficient to rely on. Biomarkers might provide help for decision-making and improve antibiotic management. The purpose of this expert panel review was to examine currently available literature on the potential role of biomarkers to improve antimicrobial prescribing, by answering three questions: 1) Which are the biomarkers available for this purpose?; 2) What is their potential role in the initiation of antibiotic therapy?; and 3) What is their role in the decision to stop antibiotic therapy? To ans…

medicine.medical_specialtymedicine.drug_class[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]AntibioticsMEDLINEContext (language use)ReviewCritical Care and Intensive Care MedicineProcalcitoninC-reactive proteinsuPARsepsis03 medical and health sciences0302 clinical medicineAntibiotic resistanceemergency medicineAntibiotic therapy[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Medicine030212 general & internal medicineIntensive care medicine030304 developmental biologyddc:6160303 health sciencessepticemie[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]business.industryPresepsin[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieproADMsTREM-1infection3. Good healthSanté publique et épidémiologie[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieBiomarker (medicine)infection;sepsis;emergency medicine;biomarker;procalcitonin;C-reactive protein;sTREM-1;suPAR;proADM;resepsinbiomarker[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieresepsinbusinessbiomarqueurBiomarkersprocalcitonin
researchProduct

Type 1 or Type 2 Myocardial Infarction in Patients with a History of Coronary Artery Disease: Data from the Emergency Department

2019

A type 2 myocardial infarction (T2MI) is the result of an imbalance between oxygen supply and demand, without acute atherothrombosis. T2MI is frequent in emergency departments (ED), but has not been extensively evaluated in patients with previously known coronary artery disease (CAD). Our study assessed the incidence and characteristics of T2MI compared to type 1 (T1MI) in CAD patients admitted to an ED. Among 33,669 consecutive patients admitted to the ED, 2830 patients with T1MI or T2MI were systematically included after prospective adjudication by the attending clinician according to the universal definition. Among them, 619 (22%) patients had a history of CAD. Using multivariable analys…

medicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematologyArticletype 2 myocardial infarctionCoronary artery disease03 medical and health sciences0302 clinical medicineInternal medicinemedicine030212 general & internal medicineMyocardial infarctionhospital mortalitybiologybusiness.industryC-reactive proteinPercutaneous coronary interventionGeneral MedicineOdds ratioEmergency departmentmedicine.diseaseTroponinConfidence intervalmyocardial infarctionCardiologybiology.proteinbusinesscoronary artery diseaseJournal of Clinical Medicine
researchProduct

Mitochondrial complex I impairment in leukocytes from type 2 diabetic patients.

2011

Diabetes is associated with oxidative stress. This study evaluated the rates of oxidative stress and mitochondrial impairment in type 2 diabetes patients. The study population consisted of 182 diabetic patients and 50 body-composition- and age-matched controls. We assessed anthropometric and metabolic parameters and mitochondrial function by evaluating mitochondrial oxygen (O2) consumption, reactive oxygen species (ROS) production, glutathione (GSH) levels, GSH/GSSG ratio, mitochondrial membrane potential, and mitochondrial complex I activity in polymorphonuclear cells from diabetes type 2 patients. We found an increase in waist circumference and augmented serum levels of triglycerides, pro…

medicine.medical_specialtymedicine.medical_treatmentType 2 diabetesMitochondrionBiologymedicine.disease_causeBiochemistryArticlechemistry.chemical_compoundInsulin resistancePhysiology (medical)Internal medicineDiabetes mellitusRotenonemedicineLeukocytesHumanschemistry.chemical_classificationReactive oxygen speciesElectron Transport Complex IInsulinMiddle Agedmedicine.diseaseMitochondriaOxygenOxidative StressEndocrinologychemistryDiabetes Mellitus Type 2Glycated hemoglobinReactive Oxygen SpeciesOxidative stress
researchProduct

Exposure to ototoxic agents and hearing loss: A review of current knowledge

2014

Several experimental and clinical studies have shown that a variety of ototoxic agents (such as drugs, industrial chemicals and noise) can cause sensorineural hearing loss. The most common ototoxic drugs used in clinical practice include: aminoglycoside and macrolide antibiotics, quinoline anti-malarials, platinum analog antineoplastics, loop diuretics, and acetylsalicylic acid. Among chemical agents with potential ototoxic properties are: organic solvents, heavy metals, organotins, nitriles, asphyxiants, and pesticides/herbicides. Acoustic exposure to high intensity and/or prolonged noise can also cause permanent threshold shifts in auditory perception. Ototoxic agents can influence audito…

medicine.medical_specialtypharmacological injuryEndolymphHearing lossototoxicity hearing loss pharmacological injury reactive oxygen speciesPharmacologyAudiologyProinflammatory cytokineSpeech and HearingAtrophyOtotoxicitymedicinehearing lossreactive oxygen specieschemistry.chemical_classificationReactive oxygen speciesbusiness.industrySettore MED/44 - Medicina Del LavoroAminoglycosidemedicine.diseaseototoxicity; hearing loss; pharmacological injury; reactive oxygen speciesSettore MED/32 - AudiologiaototoxicitySettore MED/31 - Otorinolaringoiatriamedicine.anatomical_structureOtorhinolaryngologychemistrySettore BIO/14 - FarmacologiaSensorineural hearing lossmedicine.symptombusinessHearing, Balance and Communication
researchProduct

Immune-Inflammatory Responses and Oxidative Stress in Alzheimers Disease: Therapeutic Implications

2010

Alzheimer's disease (AD) is a heterogeneous and progressive neurodegenerative disease which in Western society mainly accounts for clinical dementia. AD has been linked to inflammation and oxidative stress. Neuro-pathological hallmarks are senile plaques, resulting from the accumulation of several proteins and an inflammatory reaction around deposits of amyloid, a fibrillar protein, Abeta, product of cleavage of a much larger protein, the beta-amyloid precursor protein (APP) and neurofibrillary tangles. Inflammation clearly occurs in pathologically vulnerable regions of AD and several inflammatory factors influencing AD development, i.e. environmental factors (pro-inflammatory phenotype) an…

medicine.medical_treatmentCellular homeostasisInflammationmedicine.disease_causeImmune systemAlzheimer DiseaseDrug DiscoverymedicineAnimalsHumansSettore MED/05 - Patologia ClinicaSenile plaquesInflammationSettore MED/04 - Patologia GeneralePharmacologychemistry.chemical_classificationReactive oxygen speciesbusiness.industrymedicine.diseaseOxidative StressCytokinechemistryImmunologyInflammation MediatorsAlzheimer's disease curcuminIL-6 inflammation oxidative stressAlzheimer's diseasemedicine.symptombusinessOxidative stressCurrent Pharmaceutical Design
researchProduct

Mutacje w mitochondrialnym DNA i reaktywne formy tlenu jako czynniki wpływające na procesy starzenia się komórek i organizmów

2016

mitochondriamutacjereactive oxygen speciesstres oksydacyjnyreaktywne formy tlenuoxidative stressmitochondrialny DNAmitochondrial DNAmutations
researchProduct

HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis.

1993

Ankylosing spondylitis and seronegative spondylarthropathies such as Reiter's syndrome and reactive arthritis are strongly associated with HLA-B27. However, the mechanisms by which HLA-B27 is involved in disease susceptibility and pathogenesis are unknown. If the disease association is a consequence of HLA-B27's physiological function in antigen presentation, the disease should be mediated by cytotoxic T lymphocytes (CTLs) that recognise bacterial or self peptides presented by HLA-B27. Proof of this arthritogenic peptide model requires isolation of B27-restricted CD8 T cells from arthritic joints of patients with spondylarthropathies. An important question is whether "arthritogenic" bacteri…

musculoskeletal diseasesAdultMaleSalmonella typhimuriumYersinia InfectionsCD8 AntigensAntigen presentationArthritisArthritis ReactiveSynovial FluidmedicineCytotoxic T cellHumansReactive arthritisSpondylitis Ankylosingskin and connective tissue diseasesSpondylarthropathiesHLA-B27 AntigenYersinia enterocoliticaAnkylosing spondylitisHLA-B27business.industryGeneral MedicineChlamydia Infectionsmedicine.diseaseClone CellsImmunologySalmonella InfectionsbusinessCD8T-Lymphocytes CytotoxicLancet (London, England)
researchProduct

HLA-B27-restricted cytotoxic T lymphocyte responses to arthritogenic enterobacteria or self-antigens are dominated by closely related TCRBV gene segm…

1996

Identification of the T-cell receptors (TCR) used by synovial cytotoxic T lymphocytes (CTL) of patients with reactive arthritis (ReA) may be crucial to better understanding the pathogenetic mechanism underlying the HLA-B27 association of spondylarthropathies. The authors, therefore, sequenced 25 TCRB chains from HLA-B27-restricted CD8+ CTL clones and two clonal lines specific for self- or Yersinia enterocolitica antigen isolated from synovial fluids of 3 HLA-B27+ patients with ReA and PBL of one healthy HLA-B27+ individual. Fourteen non-HLA-B27-restricted CTL served as controls. Both autoreactive and Y. enterocolitica specific HLA-B27-restricted CTL used a highly limited set of VB genes wit…

musculoskeletal diseasesAdultMaleSalmonella typhimuriumYersinia InfectionsReceptors Antigen T-Cell alpha-betaImmunologyMolecular Sequence Datachemical and pharmacologic phenomenaChlamydia trachomatisBiologyCD8-Positive T-LymphocytesArthritis ReactiveAutoantigensPolymerase Chain ReactionProhibitinsSynovial FluidCytotoxic T cellHumansAmino Acid SequenceGene Rearrangement beta-Chain T-Cell Antigen Receptorskin and connective tissue diseasesReceptorSpondylarthropathiesGeneHLA-B27 AntigenYersinia enterocoliticaHLA-B27Antigens BacterialT-cell receptorhemic and immune systemsGeneral MedicineDNAChlamydia InfectionsCTL*ImmunologySalmonella InfectionsCD8T-Lymphocytes CytotoxicScandinavian journal of immunology
researchProduct

The cutting edge of spondylarthropathy research in the millennium

2002

In the last few years, with advances in technology and concept, research on the spondylarthropathies (SpA) has moved from random harvesting of piecemeal data to systematic evaluations of core puzzles. In the Second International Congress of Spondylarthropathies, held in Ghent, Belgium, on October 4–7, 2000, the most recent data were presented and these core puzzles were defined. The factors that are unique to SpA are 1) the site of inflammation is not only the synovium, but also the enthesis; 2) the essential predisposing gene is HLA– B27; 3) a number of other genes are required for development of ankylosing spondylitis (AS), a prototype of SpA; and 4) certain facultative intracellular Gram…

musculoskeletal diseasesAnkylosing spondylitisbusiness.industryImmunologymedicine.diseaseEnthesisRheumatologyInternational congressImmunologymedicineImmunology and AllergyPharmacology (medical)Reactive arthritisbusinessSpondylarthropathiesArthritis & Rheumatism
researchProduct

Enterobacterial Antigens with Tropism for Joint Structures and HLA-B27=Restricted Cytotoxic T-Cells in Reactive Arthritis

1995

In reactive arthritis (ReA), sterile synovitis is an immunological sequela following gastrointestinal or urogenital infection with facultatively intracellular bacteria (Yersinia, Salmonella, Shigella, Chlamydia). It is widely accepted now that the development of arthritis is closely related to the persistance of bacteria or bacterial antigens in extraarticular mucosal or lymphoid tissues (i.e. gut mucosa, gut associated lymphoid tissue, genitourinary mucosa); however, it is still unclear which host mechanisms are responsible for the poorer elimination of arthritis-causing microorganisms in those ReA patients. Bacterial components are also camed to the joints where they can be demonstrated i…

musculoskeletal diseasesGut-associated lymphoid tissueImmunologyYersiniaArthritis ReactiveTropismMicrobiologyImmune systemEnterobacteriaceaeRheumatologyAntigenSynovitismedicineAnimalsHumansImmunology and AllergySynovial fluidHLA-B27 AntigenAntigens BacterialbiologyGeneral Medicinebiology.organism_classificationmedicine.diseasemedicine.anatomical_structureImmunologyJointsBacterial antigenSynovial membraneT-Lymphocytes CytotoxicScandinavian Journal of Rheumatology
researchProduct